Damora TherapeuticsDMRA
13F holders, Q3 2024 (September 30)10holders
1famous investor
$12.15avg. 13F price*
At the end of Q3 2024, 10 institutions reported holding Damora Therapeutics Inc. (DMRA) in their 13F filings. The largest holders were Novo Holdings A/S ($1.2M), Renaissance Technologies ($260K) and UBS Group AG ($62K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Damora Therapeutics Inc.
- Filed as
- GALECTO INC (Q3 2024)
- CUSIP
- 36322Q206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $62K |
| Exits | 0 | $0 |
Ownership 10 holders
| Novo Holdings A/S | 0.06% | No change | 99,913 | $1.2M |
| Renaissance Technologies | 0.00% | Reduce -7.7% | 21,382 | $260K |
| UBS Group AG | 0.00% | New | 5,099 | $62K |
| Bank of America Corp. | 0.00% | Add +0.2% | 1,225 | $15K |
| BlackRock, Inc. | 0.00% | — | 490 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +145.9% | 346 | $4K |
| Morgan Stanley | 0.00% | Add +33.3% | 160 | $2K |
| Harbour Investments, Inc. | 0.00% | No change | 8 | $97 |
| Danske Bank A/S | 0.00% | New | 7 | $85 |
| Group One Trading LLC | 0.00% | Add +10.3% | 3 | $37 |
"% of holder's portfolio" is DMRA's weight in each manager's 13F, not the share of Damora Therapeutics Inc. the manager owns.